{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:53:56Z","timestamp":1770432836851,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ygyno.2007.11.014","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T16:24:29Z","timestamp":1198686269000},"page":"652-657","source":"Crossref","is-referenced-by-count":21,"title":["Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action\/HHMT Forum, Lake Como, March 2007"],"prefix":"10.1016","volume":"108","author":[{"given":"Alan","family":"Ashworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Balkwill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Robert C.","family":"Bast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Berek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John N.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Workman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2007.11.014_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: the size of the problem","volume":"20","author":"Sankaranarayanan","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2007.11.014_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2007.11.014_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.ede.0000164557.81694.63","article-title":"Mathematical models of ovarian cancer incidence","volume":"16","author":"Rosner","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.ygyno.2007.11.014_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.cej.0000179274.24200.9d","article-title":"Oral contraceptives and ovarian cancer: an update, 1998\u20132004","volume":"15","author":"La Vecchia","year":"2006","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ygyno.2007.11.014_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","article-title":"Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations","volume":"14","author":"Milne","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2007.11.014_bib6","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2007.11.014_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case\u2013control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2007.11.014_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2007.11.014_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00003081-200609000-00004","article-title":"Screening for ovarian cancer","volume":"49","author":"Rosentahal","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2007.11.014_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-540-37696-5_9","article-title":"Prevention and early detection of ovarian cancer: mission impossible?","volume":"174","author":"Bast","year":"2007","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.014_bib11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1055-9965.EPI-04-0404","article-title":"Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer","volume":"14","author":"Gorelik","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2007.11.014_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ejca.2006.01.009","article-title":"Endometriosis as a model for inflammation\u2013hormone interactions in ovarian and breast cancers","volume":"42","author":"Ness","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2007.11.014_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2007.11.014_bib14","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.0607959103","article-title":"Mullerian inhibiting substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer","volume":"103","author":"Pieretti-Vanmarcke","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2007.11.014_bib15","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","article-title":"Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery","volume":"65","author":"Landen","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.014_bib16","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1158\/1078-0432.CCR-06-1330","article-title":"SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation","volume":"12","author":"Duan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.014_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ygyno.2007.11.014_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/1535-7163.MCT-05-0303","article-title":"Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium","volume":"5","author":"Szlosarek","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ygyno.2007.11.014_bib19","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1200\/JCO.2005.04.127","article-title":"Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer","volume":"23","author":"Madhusudan","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2007.11.014_bib20","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1158\/1078-0432.CCR-05-2767","article-title":"Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity","volume":"12","author":"Domingo-Domenech","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.014_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2006.05.006","article-title":"Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer","volume":"102","author":"Monk","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.11.014_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1517\/14712598.5.9.1193","article-title":"Immunotherapy for gynaecological malignancies","volume":"5","author":"Coukos","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ygyno.2007.11.014_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4161\/cbt.5.7.2908","article-title":"Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity","volume":"5","author":"Benencia","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ygyno.2007.11.014_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ygyno.2007.11.014_bib25","article-title":"A novel tumor suppressor gene ARHI induces autophagy and tumor dormancy in ovarian cancer","author":"Luo","year":"2007","journal-title":"Proc Amer Assoc Cancer Research Abst #4918"},{"key":"10.1016\/j.ygyno.2007.11.014_bib26","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1158\/1535-7163.MCT-06-0640","article-title":"Spotlight on molecular profiling: \u201cIntegromic\u201d analysis of the NCI-60 cancer cell lines","volume":"5","author":"Weinstein","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ygyno.2007.11.014_bib27","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1535-7163.MCT-06-0447","article-title":"Asparagine synthetase as a causal, predictive biomarker for l-asparaginase activity in ovarian cancer cells","volume":"5","author":"Lorenzi","year":"2006","journal-title":"Molec Cancer Therapeutics"},{"key":"10.1016\/j.ygyno.2007.11.014_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.275.5298.343","article-title":"An information-intensive approach to the molecular pharmacology of cancer","volume":"275","author":"Weinstein","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2007.11.014_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0065-230X(06)96008-4","article-title":"Pharmacodynamic biomarkers for molecular cancer therapeutics","volume":"96","author":"Sarker","year":"2007","journal-title":"Adv Cancer Res"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807009225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807009225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T01:51:47Z","timestamp":1546393907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807009225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0090825807009225"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.11.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}